相关实验视频
Updated: Jan 25, 2026

20:38
Isolation and Transplantation of Hematopoietic Stem Cells HSCs
Published on: February 25, 2007
24.2K
在中国的儿科血造干细胞移植中使用抗菌剂:一项回顾性多中心队列研究
Ying Cui1, Haixin Cheng2, Biqing Liu2
1Department of Pharmacy, Capital Center for Children's Health, Capital Medical University, No. 2 Yabao Road, Beijing, China. cuiyingcpuyaoli@163.com.
BMC pediatrics
|January 23, 2026
概括
儿科造血干细胞移植 (HSCT) 患者通常会接受宽谱抗微生物和抗真菌药物适度持续时间. 治疗长度没有显示出基于年龄的显著差异.
科学领域:
- 儿科血液学 儿科血液学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 造血干细胞移植 (HSCT) 对于治疗儿科血液性恶性瘤和非恶性疾病至关重要.
- 感染构成重大威胁,导致儿科HSCT接受者的发病率和死亡率.
- 在这种脆弱人群中,抗菌剂的应用需要仔细评估.
研究的目的:
- 评估抗微生物和抗真菌剂在儿科HSCT中的利用模式.
- 分析使用的药物类型及其治疗持续时间.
- 为了确定抗微生物治疗中的任何与年龄相关的差异.
主要方法:
- 一项多中心的回顾性观察队列研究,涉及中国21家医院.
- 包括从2023年1月到2024年4月接受HSCT并接受抗菌治疗的儿科患者.
- 收集关于疾病类型,抗菌素使用 (抗生素,抗真菌药物) 和治疗持续时间的数据,并根据年龄分别对子组进行分析.
主要成果:
- 分析了186名儿科患者 (73名瘤组,113名非瘤组).
- 最常见的疾病:急性淋巴细胞白血病 (瘤组) 和粘多糖 (非瘤组).
- 经常使用:皮佩拉西林-塔扎巴克坦 (抗生素),可纳和沃里可纳 (抗真菌药). 抗菌治疗的中位数为10天 (7-14天范围).
结论:
- 儿科HSCT患者主要接受广泛的抗菌和抗真菌疗法.
- 治疗持续时间一般是中等的.
- 学龄儿童的治疗周期略长,但没有统计学意义.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.9K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.9K
Regulation of Hematopoietic Stem Cells
4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
Induced Pluripotent Stem Cells
27.3K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.3K
Antimicrobial Effectiveness
930
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
930
Adult Stem Cells
33.4K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.4K
Embryonic Stem Cells
32.1K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K

